Status:
COMPLETED
REThinkWELL- the Use of Therapeutic Game to Reduce Mental Health Symptoms in Children and Adolescents
Lead Sponsor:
Babes-Bolyai University
Collaborating Sponsors:
The Executive Agency for Higher Education, Research, Development and Innovation Funding
Conditions:
Emotional Problem
Mental Health Issue
Eligibility:
All Genders
8-16 years
Phase:
NA
Brief Summary
To test the effect of a game-based intervention in reducing clinical and subclinical symptoms of children and adolescents.
Detailed Description
The general objective of the study is to test the REThink therapeutic game for improvements in clinical and subclinical mental health symptoms in children and adolescents aged 8-16 years old from mult...
Eligibility Criteria
Inclusion
- children and adolescents aged 8 to 16 years
- subclinical level on the SDQ measure, total score, or emotional symptoms
- parental consent provided
Exclusion
- intellectual disability or physical limitations precluding the use of the online game
- does not have parental informed consent
Key Trial Info
Start Date :
May 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
279 Patients enrolled
Trial Details
Trial ID
NCT06529510
Start Date
May 20 2021
End Date
August 30 2022
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Babes-Bolyai University
Cluj-Napoca, Romania